Table 2: Baseline clinical and biochemical characteristics of 162 type 2 diabetic patients whose kidney function deteriorated and did not deteriorate over a 6.0-year follow-up.

Deterioration values
Present ()Absent ()

Male sex (, %)21, 5368, 560.72
Smokers (, %)14, 3539, 320.75
Age (years)0.01
BMI (kg/m2)0.52
Waist circumference (cm)0.52
Duration of diabetes (years)0.35
Treatment of diabetes; diet/OHA/insulin (, %)12/21/7, 30/53/1841/60/21, 34/49/170.91
Hypertension; CCB/RASi/diuretics (, %)17/16/3, 43/40/839/52/4, 32/43/30.41
HbA1c (%)0.42
Fasting PG (mg/dL)0.97
Postbreakfast PG (mg/dL)0.87
CV-HbA1c (%)0.15
Total cholesterol (mg/dL)0.998
LDL cholesterol (mg/dL)0.92
HDL cholesterol (mg/dL)0.28
Fasting TG (mg/dL)0.06
Postbreakfast TG (mg/dL)0.17
Serum creatinine (mg/dL)0.07
eGFR (mL/min/1.73 m2)0.004
eGFR (mL/min/1.73 m2/year)0.000
Uric acid (mg/dL)0.048
Systolic BP (mmHg)0.17
CV-systolic BP (%)0.82
Diastolic BP (mmHg)0.85
Urinary ACR (mg/g)0.002
log ACR0.013
Leucocyte count (103/μL)0.046
Maximum IMT (mm)0.03
Mean IMT (mm)0.02
ACR ≥ 30 mg/g (, %)17, 4336, 300.13

Mean ± SD or , %. Abbreviations are the same as in Table 1.